Biotech News
Anaptys Announces Participation at Upcoming Investor Conferences
ir.anaptysbio.com2026-05-06 14:57 EST
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive